Giant Ventral Incisional Hernia: Abdominal Wall Function, Respiratory Performance and Quality of Life (GIVINA)

March 28, 2016 updated by: Kristian Kiim Jensen, Bispebjerg Hospital

Giant Ventral Incisional Hernia: Characteristics of Abdominal Muscle-matrix, and Effect of Hernia Repair on Abdominal Wall Function, Respiratory Performance and Quality of Life

One of five patients undergoing open abdominal surgery develops an abdominal wall defect (incisional hernia) as a late complication. A fraction of these are "giant" hernia with a fascial defect beyond 10 cm. These patients are physically severely impaired, and surgical treatment is complex.

Correction of giant incisional hernias including a relatively new and minimally invasive technique, (endoscopic components separation) offers promising results. This procedure allows the abdominal muscles to be joined centrally restoring the integrity of the abdominal wall.

The treatment of patients with giant hernia is now centralized at Bispebjerg Hospital allowing for a joint study between surgeons, pulmonologists, and sports medicine researchers to define the functional and biophysical outcome from hernia repair. We hypothesize that the abdominal muscle function is significantly optimized after restoration of the abdominal wall using this technique, and that muscular function is crucial for the postoperative quality of life. Moreover, we want to assess whether this operation specifically optimizes the function and protein synthesis of the abdominal wall muscles, and exerts a beneficial effect on lung function. Finally, we will investigate if the patients with giant incisional hernia may be identified by an altered composition of their connective tissue as compared with patients who do not develop incisional hernia.

This is a prospective study of two patient groups: 1) Patients with a giant incisional hernia and 2) controls undergoing open surgery on other indications. Assessment is done pre- and perioperatively and after 1 year including muscular function, lung function, abdominal wall anatomy as provided by CT-scan, and quality of life. Specified biopsies from muscles and connective tissue are examined for muscle fiber size/type and structure by various methods, including electron microscopy and atomic force microscopy. Lung function is monitored by blood gas concentrations, Chronic Obstructive Pulmonary Disease Assessment Test questionnaire, and regular spirometry analyses. The studies are carried out by Ph.D. student Kristian Kiim Jensen, and supervised by professor in surgery Lars Nannestad Jørgensen, professor in sports medicine Michael Kjær and professor in pulmonary medicine Vibeke Backer.

Study Overview

Status

Completed

Conditions

Detailed Description

Overall project aim

The present study examines the abdominal skeletal muscle and connective tissue of patients with giant ventral incisional hernia (VIH), and to evaluate the effect of a new endoscopic components separation technique (CST) with abdominal muscle replacement upon the muscular function of the abdominal wall and quality of life in patients. The study relies on the following hypotheses:

  1. Collagen characteristics and organization are altered in patients with incisional hernia as compared with patients who do not develop incisional hernia.
  2. Reconstruction of the linea alba by endoscopic CST and medialization of the abdominal rectus muscles in patients with giant VIH leads to improvement of daily function, respiratory performance and quality of life.
  3. Abdominal wall reconstruction including CST with re-positioning of the rectus abdominis musculature increases the abdominal muscle mass and strength along with higher protein synthesis of the rectus muscles and a reduction of fibrotic skeletal muscle phenotype.

A total of 20 patients electively admitted for repair of a giant midline VIH, and 20 patients without hernias electively operated on for other indications are included. Exclusion criteria are pregnancy, severe heart- or lung disease, significant musculoskeletal disease, chemo- or radiotherapy within three months prior to the examination, and systemic corticosteroid medication. Oral and written informed consents are obtained from each participating patient.

Strength measurements of the m. rectus abdominis and the vastus lateralis of the quadriceps femoris muscle are done using a Good Strength muscle test system, both static and dynamic. The measurements are undertaken preoperatively and 1 year after surgery. A CT scan of the abdomen and thigh is done both 1 month before and 1 year after surgery to provide a detailed description of the hernia dimensions, the distance between the abdominal rectus muscles, and to determine the cross sectional area of the rectus abdominis and the vastus lateralis muscle. Lung function is determined by arterial blood gas, venous oxygen saturation, forced expiratory volume (FEV1), forced- and vital capacity (FVC, VC) including B2-receptor agonist reversal test, and maximum inspiratory- and expiratory pressure (MIP/MEP) preoperatively and 1 year postoperatively. Daily arterial blood gas is measured during postoperative admission. Lung function is determined at 1-month follow-up.

Quality of Life is assessed by the use of questionnaires. SF 36 is used for obtaining both mental and physical health scores. The St. George respiratory questionnaire and MRC are used to determine the level of daily lung impairment. Further, Carolina Comfort Scale assesses level of pain, movement limitation, and mesh sensation.

Protein turnover in both abdominal and thigh skeletal muscle is assessed by the use of a flood-primed continuous infusion of ring-13C6- phenylalanine. This will be infused four hours before surgery, and during this period 2-3 blood samples are drawn to verify stabilization of the isotope enrichment level prior to biopsy sampling. Muscle biopsy material is divided into fractions covering myofibrillar, sarcoplasmic and connective tissue proteins and analyzed using mass spectrometry to allow for calculation of protein synthesis of both contractile muscle protein and for muscle collagen. These procedures are repeated one year post surgery.

During surgery, biopsies of the linea alba, abdominal rectus muscle and the vastus lateralis muscle are taken using needle-biopsy equipment (Bergstrøm needle). One year after surgery the abdominal rectus muscle and vastus lateralis muscle again undergo the same biopsy procedure using a similar technique, but this time performed per-cutaneously under ultrasonographic guidance.

The biopsies are examined histologically for individual muscle fiber size and type (ATPase staining) as well as connective tissue and muscle structure (immunohistological examination collagen I, III and IV, laminin, desmin, tenascin-C). A section of the biopsy is used for mRNA expression by RT-PCR of COL1, COL3 and Tenascin-C. The content of collagen and both enzymatic and non-enzymatic cross-links (HP, LP and pentosidine) are determined by HPLC.

The linea alba connective tissue biopsy taken perioperative is investigated by electron microscopy for quantification of collagen fibril diameter, and atomic force microscopy to investigate fibril mechanics and 3-D structure of the connective tissue.

The change in abdominal flexor function and respiratory performance secondary to surgery is described in a paired design for both groups of patients. Quality of Life SF 36 and Carolina Comfort Scale are compared between the two groups of patients in an unpaired design and within patient groups in a paired design to assess any change induced by surgery. Differences between patient groups and change induced by surgery are assessed from the analyses on the harvested biopsy materials.

Study Type

Observational

Enrollment (Actual)

36

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Copenhagen
      • Copenhagen NW, Copenhagen, Denmark, 2400
        • Bispebjerg Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients referred to the outpatient clinic at Digestive Disease Center, Bispebjerg Hospital.

Description

Inclusion Criteria:

  • Giant ventral incisional hernia with fascial defect > 10 cm
  • Scheduled surgery on other indications
  • Provided informed consent

Exclusion Criteria:

  • Pregnancy,
  • Severe heart- or lung disease
  • Significant musculoskeletal disease
  • Chemo- or radiotherapy within three months prior to the operation
  • Systemic corticosteroid medication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Giant ventral incisional hernia
Patient with a giant ventral incisional hernia (> 10 cm fascial defect) scheduled to undergo endoscopic components separation.
Endoscopic components separation hernia repair
Control group
Patients scheduled to undergo surgery on other indications.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Abdominal wall strength
Time Frame: Preoperative and one year postoperative
Change in maximal abdominal wall strength measured by Good Strength system.
Preoperative and one year postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rectus abdominis muscle protein synthesis activity
Time Frame: Preoperative and one year postoperative
The change in activity of the protein synthesis in rectus abdominis muscles of the patients.
Preoperative and one year postoperative
Change in quality of life
Time Frame: Preoperative and one year postoperative
Changes in quality of life measured by Carolinas Comfort Scale and SF-36
Preoperative and one year postoperative
Change in respiratory function
Time Frame: Preoperatively, one month, and year postoperative
Change in respiratory function as measured by spirometry and maximal inspiratory and expiratory pressure.
Preoperatively, one month, and year postoperative
Maximal thigh strength
Time Frame: Preoperatively and one year postoperative
Change in maximal thigh strength as measured by Power-Rig method.
Preoperatively and one year postoperative
Rectus abdominis muscle phenotype
Time Frame: Preoperatively and one year postoperative
Changes in Rectus abdominis muscle phenotype due to hernia repair.
Preoperatively and one year postoperative
Connective tissue characteristics
Time Frame: Perioperatively
Differences in connective tissue characteristics in patients with and without ventral incisional hernia.
Perioperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Lars Nannestad Jorgensen, Dr. Msc, Digestive disease center, Bispebjerg Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2013

Primary Completion (ACTUAL)

March 1, 2016

Study Completion (ACTUAL)

March 1, 2016

Study Registration Dates

First Submitted

December 10, 2013

First Submitted That Met QC Criteria

December 12, 2013

First Posted (ESTIMATE)

December 13, 2013

Study Record Updates

Last Update Posted (ESTIMATE)

March 29, 2016

Last Update Submitted That Met QC Criteria

March 28, 2016

Last Verified

March 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • H-1-2013-097

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Incisional Hernia

Clinical Trials on Endoscopic components separation

3
Subscribe